Substantia nigra dopaminergic neuron density in PD, PSP and MSA: An interim clinicopathological analysis
Objective: To investigate substantia nigra pars compacta (SNc) area together with dopaminergic neuron count and density in atypical parkinsonisms in relation to Parkinson’s disease (PD)…Prevalence of Parkinson’s disease and Atypical Parkinsonisms in Colombia: Data from the national health registry 2016-2021
Objective: To estimate prevalence of Parkinson’s Disease (PD) and Atypical Parkinsonisms and characterise the diagnosed population in a country with a development economy Background: The…Gait and Balance Characteristics in Atypical Parkinsonian Syndromes
Objective: To characterize a cohort of patients with multiple system atrophy (MSA) and progressive supranuclear gaze palsy compared to idiopathic Parkinson’s disease (IPD) patients according…Retinal thickness as a marker of disease progression in progressive supranuclear palsy
Objective: We measured changes of retinal thickness, and compare them with clinical features and intracranial neurodegeneration in progressive supranuclear palsy (PSP) cohort. Background: PSP has a…A trail towards understanding cognitive impairment in PSP
Objective: To investigate cognitive impairment in 22 patients with Progressive Supranuclear Palsy with Richardson syndrome (PSP-RS). Background: PSP is a neurodegenerative disease and common differential…APOE effect on Progressive Supranuclear Palsy phenotypes
Objective: To assess the influence of the Apolipoprotein E (APOE) gene variants on Progressive supranuclear palsy (PSP) phenotypic expression. Background: PSP is a rare neurodegenerative…Benign Progressive Supranuclear Palsy: mild pathology associated with parkinsonism
Objective: Objective: To describe the clinical presentation and neuropathology of cases where the degree of tau pathology is mild, and the neuronal loss is anatomically…Unusual Progressive Supranuclear Palsy: a case report
Objective: Introduction: Progressive supranuclear palsy (PSP) is a rare brain condition. It is predominantly a sporadic disease that occurs between 45 and 75 years of…Predictors of survival in Progressive Supranuclear Palsy in a Tunisian cohort
Objective: To investigate survival and its determinants in a Tunisian cohort of Progressive Supranuclear Palsy (PSP). Background: PSP is a neurodegenerative tauopathy characterized by faster…Early detection of change in motor and cognitive symptoms in a longitudinal Progressive Supranuclear Palsy cohort – the OxQUIP study.
Objective: We aimed to determine longitudinal changes in motor and cognitive features of Progressive Supranuclear Palsy using multiple closely spaced follow-up timepoints over a period…
- « Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 42
- Next Page »